Aurinia Pharmaceuticals Inc.
AUPHUS売上高
$283M
百万USD
営業利益
$105M
百万USD
純利益
$287M
百万USD
ROE
49.4%
最新FY
EPS
$2.07
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $1M | $-50M | - |
| FY2021 | Q2 | $7M | $-47M | $-0.37 |
| FY2021 | Q3 | $15M | $-50M | $-0.39 |
| FY2021 | FY | $46M | $-181M | $-1.40 |
| FY2022 | Q1 | $22M | $-38M | $-0.27 |
| FY2022 | Q2 | $28M | $-36M | $-0.25 |
| FY2022 | Q3 | $56M | $-9M | $-0.06 |
| FY2022 | FY | $134M | $-108M | $-0.76 |
| FY2023 | Q1 | $34M | $-26M | $-0.18 |
| FY2023 | Q2 | $41M | $-11M | $-0.08 |
| FY2023 | Q3 | $55M | $-13M | $-0.09 |
| FY2023 | FY | $176M | $-78M | $-0.54 |
| FY2024 | Q1 | $50M | $-11M | $-0.07 |
| FY2024 | Q2 | $57M | $1M | $0.01 |
| FY2024 | Q3 | $68M | $14M | $0.10 |
| FY2024 | FY | $235M | $6M | $0.04 |
| FY2025 | Q1 | $62M | $23M | $0.16 |
| FY2025 | Q2 | $70M | $22M | $0.16 |
| FY2025 | Q3 | $73M | $32M | $0.23 |
| FY2025 | FY | $283M | $287M | $2.07 |
| FY2026 | Q1 | $78M | $34M | $0.25 |
財務データ
| 指標 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| 売上高 | $50M | $46M | $134M | $176M | $235M | $283M |
| 営業利益 | $-104M | $-181M | $-111M | $-92M | $-5M | $105M |
| 純利益 | $-103M | $-181M | $-108M | $-78M | $6M | $287M |
| 総資産 | $464M | $543M | $471M | $548M | $551M | $752M |
| 純資産 | - | - | - | - | - | - |
| 自己資本 | $408M | $479M | $405M | $378M | $377M | $581M |
| 営業CF | $-70M | $-158M | $-80M | $-33M | $44M | $136M |
| EPS | - | $-1.40 | $-0.76 | $-0.54 | $0.04 | $2.07 |
| BPS | $3.18 | $3.38 | $2.84 | $2.64 | $2.75 | $4.37 |
| ROE | -25.2% | -37.8% | -26.7% | -20.6% | 1.5% | 49.4% |